Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Discover effective ways to make money quickly to pay debts. Regain financial stability with practical and fast solutions.
21,535 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
As markets bounce between frenzy and caution, investors are weighing two paths: a focused bet on seven mega-cap names...
Dividend investing can deliver steady income even when markets swing. Here are three no-brainer dividend stocks right...
Employer ghosting has escalated to a three-year peak, with more than half of job seekers reporting no response after ...
If you’re hunting for reliable dividend income, you’ve likely wondered whether should bristol myers squibb deserves a...
Two Dividend Kings confront mounting cash-flow pressures and strategic shifts as 2026 approaches. This story examines...
Bruker's Q1 2026 earnings transcript can reveal much about the stock's path in 2026. This guide breaks down what to l...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
Delta Air Lines CEO Ed Bastian discarded an AI-generated commencement draft and rewrote his address by hand, arguing ...
EWZ’s semi-annual payouts are highly dependent on Petrobras and Vale, delivering big checks in buoyant commodity mark...
HSBC upgraded Cisco to Buy and lifted the price target as the company moves toward a $6 billion AI revenue goal for F...
Brokerages are reclaiming control over listing data as portals monetize information. The shift reshapes lending, pric...